Clinical Omics – Products

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs.

New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay, coupled with new Ion AmpliSeq HD technology, extend industry-leading Oncomine menu and enable panel design customization.

Thermo Fisher Scientific today announced the Ion GeneStudio S5 Series, a new line of bench top next-generation sequencing (NGS) instruments that enable low cost per sample for small and large projects across multiple research applications.

The FDA-approved next-generation sequencing (NGS) kit will help clinicians identify which patients are eligible for treatment of metastatic colorectal cancer.

The Thermo Scientific Cascadion SM Clinical Analyzer brings together the ease of use of clinical analyzers with the selectivity and sensitivity of liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Bruker’s novel Proteoform Profiling™ 1.0 solution enables a powerful new life-science research and translational research workflow.

Thermo Fisher Scientific has strengthened its industry-leading analytical instruments platform with innovative systems designed to help pharmaceutical and biologics producers more efficiently discover and develop candidate drugs.

Company has introduced its new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data.

New solutions enable users to tailor automation and screening to their application and enhance a broad array of workflows.

Access to a section of the platform will be enabled via a new mobile app at the American Society of Human Genetics (ASHG) 2015 conference, October 6th-10th, Baltimore, Maryland.